Obesity or being overweight is a major health condition that is linked to some of the top causes of mortality, such as heart disease, stroke, and diabetes, as well as an increased risk of some types of cancer
Semaglutide hair loss is usually temporary
To apply the AGS Beers Criteria, prescribers and pharmacists must identify the PIMs and, when clinically appropriate, consider safer pharmacologic or nonpharmacologic alternatives
However, the commercial did not disclose any side effects or safety information required for a US Food and Drug Administration (FDA)-approved drug
Abstract Background Recent studies suggest that tirzepatide, a dual glucose-dependent insulinotropic-peptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has significant weight loss effects
Regul Pept 2013